The Impact of Fluid Balance on Short- and Long-Term Respiratory Outcomes in Extremely Premature Neonates: Results from the PENUT Study
Saturday, April 23, 2022
3:45 PM – 4:00 PM US MT
Location: Convention Center: Mile High Ballroom 3AB
CE: Enduring CME: 0.25
Publication Number: 1635.2
Michelle Starr, Indiana University School of Medicine and Riley Hospital for Children, Indianapolis, IN, United States; Russell L. Griffin, UNIVERSITY OF ALABAMA AT BIRMINGHAM, Birmingham, AL, United States; Katja M. Gist, Children's Hospital Medical Center (Cincinnati), Cincinnati, OH, United States; Jeffrey L. Segar, Medical College of Wisconsin, Brookfield, WI, United States; rupesh raina, Akron Children's Hospital, Brecksville, OH, United States; Ronnie Guillet, Golisano Children's Hospital at The University of Rochester Medical Center, Rochester, NY, United States; Saudamini Nesargi, St. John's medical College Hospital, Bangalore, Karnataka, India; Shina Menon, University of Washington/Seattle Children's Hospital, Seattle, WA, United States; Nekayla Anderson, UAB, 3113 reserve court, AL, United States; David Askenazi, UAB, Birmingham, AL, United States; David Selewski, Medical University of South Carolina College of Medicine, Charleston, SC, United States
Presenting Author(s)
Michelle C. Starr, MD MPH (she/her/hers)
Assistant Professor of Pediatrics Indiana University School of Medicine Indinapolis, IN, United States
Jeffrey L. Segar, MD: ● Pfizer (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
rupesh raina, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ronnie Guillet, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saudamini Nesargi, DNB: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Shina Menon, MD: ● AKI Foundation (Currently Ongoing) (Products/Services: Consultant). ● Nuwellis Inc (Currently Ongoing) (Products/Services: Consultant).
Nekayla Anderson, Master of Public Health: I do not have any relevant financial / non-financial relationships with any proprietary interests.
David Askenazi, MD, MSPH: ● Baxter (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Bioporto (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Medtronic (Products/Services: Consultant). ● Nuwellis (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Seastar (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
David Selewski, MD, MS: ● Travere (Ended In the Past 24 Months) (Products/Services: Consultant).
